08. March 2023

ARQIS has advised Omnes Capital on the acquisition of a stake in the Austrian-German photovoltaic specialist CCE. Omnes will support CCE´s transformation into a leading European independent power producer (IPP) and is expected to invest a three-digit million amount in the company.

Paris-based private equity and infrastructure investor Omnes has acquired a stake in leading Austrian- German PV developer CCE, headquartered in Vienna. The investment has been carried out through Capenergie 5, which is Omnes’ fifth vintage focused on renewable energy. The funds provided by Omnes are intended to accelerate CCE’s growth toward becoming a leading international IPP.

CCE is the result of a merger between two PV developers, Austria-based Clean Capital Energy and Germany-based enernovum. The two companies were founded in 2010 and have been working together successfully for several years. CCE Holding was created in 2021 together with Ärzteversorgung Thüringen, combining all operating units and the project pipeline of over 4 GW. After Ärzteversorgung Thüringen having accompanied and significantly financed CCE’s corporate development to date, Omnes’ involvement as a strategic partner will enable CCE to expand its longterm ownership portfolio and accelerate its transition to becoming a leading independent power producer. CCE is already one of the leading developers of PV power plants in connection with flexible energy storage systems in southern and central Europe.

Omnes is a major player in private equity and infrastructure. With more than €5 billion in assets under management, Omnes provides companies with the equity capital they need to grow. The team around ARQIS partner Mirjam Boche advises Omnes Capital regularly; inter alia on the solar energy joint venture with the German solar power developer ILOS New Energy.

Advisors to Omnes Capital

ARQIS (Dusseldorf): Dr. Mirjam Boche (Leading Partner, M&A), Dr. Friedrich Gebert (Public & Regulatory); Counsel: Dr. Nima Hanifi-Atashgah (M&A); Associates: Luise Schüling (Public & Regulatory), Hannah Düwel (Public & Regulatory), Dr. Bernhard Gröhe (Public & Regulatory), Conrad Wiza (M&A)